AAAAAA
Results:
1-12
|
Results: 12
Authors:
GREGOOR PJHS
HESSE CJ
VANGELDER T
VANDERMAST BJ
IJZERMANS JNM
VANBESOUW NM
WEIMAR W
Citation: Pjhs. Gregoor et al., RELATION OF MYCOPHENOLIC-ACID TROUGH LEVELS AND ADVERSE EVENTS IN KIDNEY ALLOGRAFT RECIPIENTS, Transplantation proceedings, 30(4), 1998, pp. 1192-1193
Authors:
VANRIEMSDIJK IC
HESSE CJ
LOONEN EHM
BAAN CC
ZIETSE R
WEIMAR W
Citation: Ic. Vanriemsdijk et al., TNF-ALPHA - BALANCE BETWEEN MESSENGER-RNA, SERUM LEVELS AND SOLUBLE RECEPTORS PATIENTS ON HEMODIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 986-986
Authors:
VANBOMMEL EFH
HESSE CJ
JUTTE NHPM
ZIETSE R
BRUINING HA
WEIMAR W
Citation: Efh. Vanbommel et al., IMPACT OF CONTINUOUS HEMOFILTRATION ON CYTOKINES AND CYTOKINE INHIBITORS IN OLIGURIC PATIENTS SUFFERING FROM SYSTEMIC INFLAMMATORY RESPONSESYNDROME, Renal failure, 19(3), 1997, pp. 443-454
Authors:
VANRIEMSDIJK IC
HESSE CJ
ZIETSE R
WEIMAR W
Citation: Ic. Vanriemsdijk et al., THE BIOLOGICAL SIGNIFICANCE OF THE HIGH-LEVELS OF SOLUBLE TNF RECEPTORS IN PATIENTS ON CHRONIC-HEMODIALYSIS, Kidney international, 52(2), 1997, pp. 567-567
Authors:
VANRIEMSDIJK IC
HESSE CJ
ZIETSE R
WEIMAR W
Citation: Ic. Vanriemsdijk et al., BIOLOGICAL SIGNIFICANCE OF THE HIGH-LEVELS OF SOLUBLE TNF RECEPTORS IN PATIENTS ON CHRONIC-HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1268-1268
Authors:
VANGELDER T
BALK AHMM
JONKMAN FAM
ZIETSE R
ZONDERVAN P
HESSE CJ
VAESSEN LMB
MOCHTAR B
WEIMAR W
Citation: T. Vangelder et al., A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION, Transplantation, 62(1), 1996, pp. 51-55
Authors:
HESSE CJ
JUTTE NHPM
Citation: Cj. Hesse et Nhpm. Jutte, DETECTION OF ANTIIDIOTYPIC ANTIBODIES AFTER OKT3 TREATMENT BY FLOW-CYTOMETRY, Transplantation, 61(1), 1996, pp. 169-169
Authors:
VANGELDER T
MULDER AH
BALK AHMM
MOCHTAR B
HESSE CJ
BAAN CC
VAESSEN LMB
WEIMAR W
Citation: T. Vangelder et al., INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS, The Journal of heart and lung transplantation, 14(2), 1995, pp. 346-350
Authors:
HESSE CJ
VANGELDER T
VAESSEN LMB
KNOOP CJ
BALK AHMM
YZERMANS JNM
JUTTE NHPM
WEIMAR W
Citation: Cj. Hesse et al., PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION, Immunopharmacology, 30(3), 1995, pp. 237-246
Authors:
VANGELDER T
KNOOP CJ
HESSE CJ
VAESSEN LMB
BALK AHMM
YZERMANS JNM
WEIMAR W
Citation: T. Vangelder et al., PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(1), 1995, pp. 856-858
Authors:
VANGELDER T
ZIETSE R
MULDER AH
YZERMANS JNM
HESSE CJ
VAESSEN LMB
WEIMAR W
Citation: T. Vangelder et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY-TRANSPLANTATION, Transplantation, 60(3), 1995, pp. 248-252
Authors:
ZIETSE R
VANSTEENBERGE EPM
HESSE CJ
VAESSEN LB
IJZERMANS JNM
WEIMAR W
Citation: R. Zietse et al., SINGLE-SHOT, HIGH-DOSE RABBIT ATG FOR REJECTION PROPHYLAXIS AFTER KIDNEY-TRANSPLANTATION, Transplant international, 6(6), 1993, pp. 337-340
Risultati:
1-12
|